These findings indicate that GBM cells activate the AKT pathway in SVGP12 cells, resulting in increased expression of SERPINH1 and COL5A1 (Figure 4C and 4D, one-way ANOVA, P < 0.05; statistical results shown on the right). The gene discussed is COL5A1; the disease is glioblastoma.